PTJ
LOXO

Paul Tudor Jones’s Loxo Oncology, Inc LOXO Stock Holding History

Paul Tudor Jones’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,514
Closed -$232K – 1393
2017
Q3 		$232K Sell
2,514
-7,928
-76% -$616K 0.01% 914
2017
Q2 		$837K Buy
+10,442
New +$579K 0.03% 391

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Paul Tudor Jones's LOXO Position: Q4 2017 in Review

Paul Tudor Jones sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 2,514 shares — an estimated $232K sold.

Paul Tudor Jones first reported a position in LOXO in Q2 2017 and held it in 2 quarters. The position peaked at $837K in Q2 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • Paul Tudor Jones reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 2,514 Loxo Oncology, Inc shares in Q4 2017, an estimated $232K.
  • Paul Tudor Jones first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 2 quarters.
  • Paul Tudor Jones's Loxo Oncology, Inc position peaked at $837K in Q2 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Tudor Investment Corp's 13F filing for Q4 2017, filed 14 Feb 2018.